EUVIMEDEUVIMED entdecken
Crossref

The extracellular-matrix-remodeling capability exposes therapeutic vulnerability in a subset of renal cell carcinomas with tumor thrombi

Qi Zhang, Yezhen Tan, Qiyang Liang, Liangyou Gu, Yue Shi, Yan Huang, Xiubin Li, Jie Qi, Cheng Peng, Hanfeng Wang, Yaohui Wang, Kan Liu und 7 weitere

Developmental Cell · 2025

DOI: 10.1016/j.devcel.2025.07.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developmental Cell, 2025. Verfasst von Qi Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: China National Center for Bioinformation, Beijing 100101, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; U…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Extracellular Matrix, Kidney Neoplasms, Thrombosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 152 Literaturangaben. Gefördert von: Chinese PLA General Hospital, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellExtracellular MatrixKidney NeoplasmsThrombosisHumansAnimalsMiceTumor MicroenvironmentCell Line, TumorPrognosisProtein-Lysine 6-OxidaseFemaleGene Expression Regulation, NeoplasticMaleMacrophages

Stichwörter der Autor:innen

extracellular matrixphenotypic plasticityrenal cell carcinoma with tumor thrombustumor immune barrier

Substanzen

Protein-Lysine 6-Oxidase

Autor:innen und Institutionen

  • China National Center for Bioinformation, Beijing 100101, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Department of Urology, Chinese PLA General Hospital, Beijing 100039, China; Medical School of Chinese PLA, Beijing 100853, China.
  • Department of Urology, Chinese PLA General Hospital, Beijing 100039, China.
  • China National Center for Bioinformation, Beijing 100101, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
  • China National Center for Bioinformation, Beijing 100101, China; Institute for Regenerative Medicine, Shanghai East Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem C…
  • Department of Urology, Chinese PLA General Hospital, Beijing 100039, China. Electronic address: xzhang301@163.com.

Förderung

  • Chinese PLA General Hospital
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Q., Tan, Y., Liang, Q., Gu, L., Shi, Y., Huang, Y., Li, X., Qi, J., Peng, C., Wang, H., Wang, Y., Liu, K., Cai, T., He, Y., Huang, Q., Zhang, X., Wang, B., Ma, X., & Ci, W. (2025). The extracellular-matrix-remodeling capability exposes therapeutic vulnerability in a subset of renal cell carcinomas with tumor thrombi. Developmental Cell. https://doi.org/10.1016/j.devcel.2025.07.010

Vancouver

Zhang Q, Tan Y, Liang Q, Gu L, Shi Y, Huang Y, et al. The extracellular-matrix-remodeling capability exposes therapeutic vulnerability in a subset of renal cell carcinomas with tumor thrombi. Developmental Cell. 2025. doi:10.1016/j.devcel.2025.07.010

BibTeX
@article{Zhang2025,
  author = {Zhang, Qi and Tan, Yezhen and Liang, Qiyang and Gu, Liangyou and Shi, Yue and Huang, Yan and Li, Xiubin and Qi, Jie and Peng, Cheng and Wang, Hanfeng and Wang, Yaohui and Liu, Kan and Cai, Tianwei and He, Yudan and Huang, Qingbo and Zhang, Xu and Wang, Baojun and Ma, Xin and Ci, Weimin},
  title = {The extracellular-matrix-remodeling capability exposes therapeutic vulnerability in a subset of renal cell carcinomas with tumor thrombi},
  journal = {Developmental Cell},
  year = {2025},
  doi = {10.1016/j.devcel.2025.07.010}
}
Kostenlos starten →